SARS-CoV-2 Testing of Emergency Department Patients Using cobas(®) Liat(®) and eazyplex(®) Rapid Molecular Assays

Rapid testing for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) of patients presenting to emergency departments (EDs) facilitates the decision for isolation on admission to hospital wards. Differences in the sensitivity of molecular assays have implications for diagnostic workflows. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Egerer, Renate, Edel, Birgit, Hornung, Franziska, Deinhardt-Emmer, Stefanie, Baier, Michael, Lewejohann, Jan-Christoph, Pfister, Wolfgang, Löffler, Bettina, Rödel, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341290/
https://www.ncbi.nlm.nih.gov/pubmed/37443639
http://dx.doi.org/10.3390/diagnostics13132245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341290/
https://www.ncbi.nlm.nih.gov/pubmed/37443639
http://dx.doi.org/10.3390/diagnostics13132245

Ejemplares similares